Patient Home
Welcome to Health Vidya. Discover trusted care and your own health — all in one place.
These highlights do not include all the information needed to use HUMALOG MIX75/25 safely and effectively. See full prescribing information for HUMALOG MIX75/25. HUMALOG MIX75/25 (insulin lispro protamine and insulin lispro) injectable suspension, for subcutaneous use Initial U.S. Approval: 1999
Medication labelWhy this: Advisory · dailymed-prescription
HUMALOG Mix75/25 is indicated to improve glycemic control in adults with diabetes mellitus. Limitations of Use: The proportions of rapid-acting and intermediate-acting insulins in HUMALOG Mix75/25 are fixed and do not allow for basal versus prandial dose adjustments.
- generic_name
- insulin lispro
- product_names
- Insulin lispro
- ndc
- 0002-7511, 0002-7511-01, 0002-8797, 0002-8797-01, 0002-8797-59, 0002-8797-61
- group
- drugs
- license
- us-gov-pd
- attribution
- Courtesy of the National Library of Medicine
- reviewed
- 2026-09-18
- language
- en